Hypoplastic left heart syndrome (HLHS) is a serious cardiac disorder characterized by underdevelopment of the left heart structures, including the left ventricle, mitral valve, aorta, and ascending aorta. This pathology is critical for newborns, as it disrupts normal blood circulation, which is the cause of significant risks to the lives of infants. HLHS usually manifests itself in the first weeks of life, and in the absence of appropriate treatment leads to rapid deterioration of the patient's condition and high mortality rates. Cardiovascular failure caused by insufficient oxygen supply to the body becomes the main problem in such patients, which makes the need for early diagnosis and adequate treatment especially urgent.
History of the disease and interesting historical facts
Historically, hypoplastic left heart syndrome was first described in the medical literature in the mid-20th century, when systematic studies of congenital heart defects began. The first presentations of this syndrome appeared in the 1970s, when scientists noted that this disease could be a cause of sudden cardiac death in newborns. Major advances in the diagnosis of HLS were made possible by the introduction of echocardiography and other imaging technologies, which significantly improved the understanding and identification of this pathology. Interestingly, until the mid-20th century, many children with HLS did not survive, but with the development of surgical practice, the possibility of saving such patients has become much more real.
Epidemiology
According to current data, hypoplastic left heart syndrome occurs with a frequency of approximately 2-3 cases per 10,000 live births. This pathology is one of the most common congenital heart defects requiring surgical intervention in early childhood. According to studies, the disease is more often observed in boys than in girls, with a ratio of 3:1. It can also be associated with other developmental anomalies, which emphasizes the importance of comprehensive treatment and monitoring of such patients.
Genetic predisposition to this disease
Recent studies have shown that certain gene mutations may be associated with the development of hypoplastic left heart syndrome. In particular, associations have been found with mutations in genes encoding transcription factors that play a critical role in embryonic heart development. There is evidence that children with HLHS may have hereditary pathologies, such as genetic syndromes such as Down syndrome and Turner syndrome. Detectable tests for mutations and chromosomal abnormalities help to identify a predisposition to this disease and improve pregnancy management strategies if they are present.
Risk factors for the development of this disease
Risk factors for the development of hypoplastic left heart syndrome can be divided into external and internal. External factors include:
- Environmental impacts such as pollution;
- Effects of drugs during pregnancy;
- Bad habits (smoking, alcohol) in the mother;
- Maternal infectious diseases, such as rubella.
Internal risk factors include:
- Family history of cardiovascular disease;
- Age of parents over 35 years;
- The presence of previously identified genetic or chromosomal abnormalities in the mother.
Diagnosis of this disease
Diagnosis of hypoplastic left heart syndrome begins with a clinical examination of the newborn, during which key symptoms are identified:
- Bluish discoloration of the skin;
- Short-term episodes of severe shortness of breath;
- Weak pulse and high heart rate;
- Lethargy and decreased activity.
Laboratory tests include blood oxygen levels, which may demonstrate hypoxemia. Radiological examinations, such as chest X-rays, can reveal changes in the structure of the heart and blood vessels. Echocardiography is the primary imaging test that helps establish the diagnosis in the early stages. The differential diagnosis includes comprehensive exclusion of other cardiovascular diseases, such as coarctation of the aorta and Eismann syndrome.
Treatment
Treatment of hypoplastic left heart syndrome is complex and varies depending on the severity of the disease. As a rule, in the early stages it is necessary to conduct supportive therapy using drugs that improve heart function.
Pharmacological treatment includes:
- Diuretics to reduce swelling;
- ACE inhibitors to reduce the load on the heart;
- Gradual use of other cardiac glycosides.
Surgical treatment often requires a number of procedures, including:
- Creation of anastomoses between the pulmonary artery and the aorta (for example, the Blalac operation);
- Correction of congenital defects.
In addition, some children require a heart transplant, especially if they have developed cardiovascular failure.
List of medications used to treat this disease
Medicines used for hypoplastic left heart syndrome:
- Furosemide (Lasix);
- Perindopril;
- Digoxin;
- Atenolol;
- Aspirin (as indicated).
Disease monitoring
Monitoring of patients with hypoplastic left heart syndrome includes regular cardiologist examinations, echocardiography, and monitoring of blood oxygen levels. The prognosis for children with this pathology has improved significantly due to modern surgical techniques. However, patients may experience complications, including cardiac arrhythmias and heart failure, which require constant monitoring and early intervention.
Age-related features of the disease
Hypoplastic left heart syndrome has different features depending on the patient's age. In newborns, the disease is most often accompanied by pronounced clinical symptoms and requires immediate intervention. In older children, latent forms are possible, which can manifest as problems with physical activity or development. In adolescence, the load on the heart increases, which can lead to deterioration in health.
Questions and Answers
- What are the early signs of hypoplastic left heart syndrome? Early signs include cyanosis, shortness of breath, and poor activity in the newborn.
- Can GLTS be prevented? Guardian factors, such as monitoring the mother's health during pregnancy, may reduce the risks, but complete prevention cannot be guaranteed.
- What surgical interventions are used to treat this syndrome? The main operations include anastomoses and correction of congenital heart defects.
- What is the prognosis for children with HLHS? The prognosis has improved significantly thanks to modern treatment methods, but the need for constant monitoring remains relevant.
- When is a heart transplant necessary? Heart transplantation is required for critical heart failure when other treatments are ineffective.
Dr. Oleg Korzhikov, a cardiac surgeon, notes that an important aspect in the treatment of hypoplastic left heart syndrome is psychological support for the family. Parents need to learn the basics of child care and mutual understanding with medical personnel. "Don't be shy about asking questions to doctors and looking for all possible treatment options. Your active participation in the process will help your child," the doctor emphasizes.
